Intelligent Living, Inc. (OTCMKTS:ILIV) Caught in Accelerating Fall
Intelligent Living, Inc. (OTCMKTS:ILIV) seems to have reached the limit of its powers in the latest climb, and is now retreating even faster. ILIV slid back by 29% on Monday, reaching $0.011, on selling volumes above $1.53 million. ILIV rose fast in the last few weeks, but the developments around its entry into medical cannabis is slowing down. 
The latest PR from the company is that ILIV launched a new medical and dietetic advice website- but that platform seems still to be rather new and inactive, with limited content and limited user contributions. Also, as the message is dated back to February 21st, it is already too old to fuel investors’ interest, and in any case, the major appeal of ILIV is that of a company with a potential as a marijuana stock. 
For now, the company’s website sells a technique for “bio-nutrirional evaluation”, and a series of herbal supplements targeted to various illnesses. Both product classes are tied up, and even the company’s president, Dr. Larry LeGunn, mentioned that for customers of the diagnostic tools, supplements would be offered as a means of treatment. Now, it remains to be seen if this business model, based on the health and wellness general hype, will lead the company to better financial positions.
Unfortunately, there is still no detailed mention of how ILIV would manage to integrate medical cannabis into its mix of products. Despite this, ILIV is still considered an opportunity for gains, as investors’ forums proclaim an optimism, and expect the selling series to end soon. ILIV was last promoted on February 17th, and despite the lack of new messages, the ticker is showing enough upward momentum, which may keep up in the next few days.
A more successful story from the supplement sector comes from Creative Edge Nutrition, Inc. (OTCMKTS:FITX), a company that also shot up from extremely low prices, and now has been pushing against a ceiling at nine cents. FITX is better represented in online sales compared to ILIV, and also its promotional effort were longer, due to an earlier arrival as an in-demand marijuana stock.
Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH) is yet another company that holds many risk warnings, but still managed an impressive climb. In the past week, though, EAPH also started to retreat toward $0.05.
If you still like those businesses which sell alternative health promises, keep in mind that they still have to prove the viability of their promised cannabis products. Keep in mind that the climbs from the very low levels are created by publicity and other unusual efforts, and that a drop in price may follow soon after the news slack off for a few days.
